MAIN RESULTS
Data from 1942 (83%) of participants were available for cluster analysis. At baseline, 503 participants were in the best health state cluster (25.9%), 992 in the second best (51.1%), 145 in the middle (7.47%), 53 in the second worst (2.73%) and 249 (12.8%) in the worst. Postbaseline data were available for 1635 participants (70%). At year 1, 269 participants were closest to best health state cluster (23%). From year 1 to year 2, 209 (13%) were closest to best health state cluster. A sustained favourable longterm outcome was achieved by 157 participants (10%). Over 3 years, 85% (n=688) did not have a sustained shift in health state, 10% (n=84) had improved and 4% (n=34) had worsened health states. Nine baseline variables were signifi cantly associated with sustained favourable long-term outcome. The likelihood of a sustained favourable long-term outcome was associated with being employed (OR 1.98, 95% CI 1.34 to 2.91); ability to shop independently (OR 1.76, 95% CI 1.19 to 2.59); ability to undertake independent leisure activities (OR 1.75, 95% CI 1.10 to 2.79); experiencing clearer thoughts from medications (OR 1.21, 95% CI 1.04 to 1.40); better quality of life (OR 1.64, 95% CI 1.32 to 2.03); better global functioning (OR 1.04, 95% CI 1.02 to 1.06); and more daily activities (OR 1.27, 95% CI 1.06 to 1.52). The likelihood of experiencing a sustained favourable long-term outcome was lower in those who had received individual therapy (OR 0.47, 95% CI 0.25 to 0.88), or who had been a victim of crime (OR 0.38, 95% CI 0.17 to 0.85).
CONCLUSIONS
Most people with schizophrenia in naturalistic care settings have no sustained change in health status over 3 years. Better functioning on certain measures at baseline predicted sustained favourable outcome over this period. ▶ Notes and references are available online only at http://ebmh.bmj.com COMMENTARY C uyún-Carter et al report the fi ndings of a 3 year extensive non-randomised study on patients with schizophrenia spectrum disorders treated in routine clinical practice. A major objective of this study was to report on the treatment outcome and respective predictors. Apart from the large study sample, the most impressive issue is the multi-dimensional defi nition of outcome including symptoms, functioning and care utilisation. Based on this criteria, only 10% achieved a favourable and sustained outcome, which is somewhat lower than generally found in schizophrenia cases. 1 Of various assessments, many baseline characteristics emerged as signifi cant predictors which can be summarised as 'favourable baseline characteristics predict favourable outcome'; a result representative for schizophrenia. In multiple logistic regression analysis, nine predictors remained signifi cant and the authors conclude that this might enable individual treatment decisions. Unfortunately, many different predictors have been identifi ed in several studies. However, so far, there are no set of valid predictors which enables individual prognosis. 2 Among others, this is due to the approach of a multiple regression analysis which identifi es predictors which best represent the analysed sample, however, this result cannot be generalised to other samples.
ABSTRACTED FROM
Given the large sample in the present study, it would have been reasonable to primarily split and cross-validate the set of predictors identifi ed in both samples separately. In addition, identifying individuals requires distinct criteria and cut-off points which do not seem feasible based on the study results (just small differences in the means between the favourable vs not favourable patients). Furthermore, the authors interpret predictors causally by concluding that training in role and occupational functioning might lead to favourable outcome not considering that this association might be caused by a third (moderator) variable (eg, neurophysiological factors which can hardly be affected by psychosocial treatment). Thus, the result of this comprehensive study in real-world clinical setting contributes data to the objective of individual prognosis and treatment decisions; however, more research is needed in this fi eld.
